Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
170.20    -0.20 (-0.12%)
Bid:
170.40
Ask:
171.00
Spread: 0.60 (0.352%)
Market Cap: £208.86m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

SThree: Board Changes

19 Apr 2022 07:00

SThree (STEM) SThree: Board Changes 19-Apr-2022 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


19 April 2022

 

 

SThree plc

 

Board Changes

 

 

SThree plc ("SThree" or the "Group"), the only global pure-play specialist staffing business focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), announces that it has received notice from Anne Fahy, Non-Executive Director of the Company, of her resignation from the Board with immediate effect. Accordingly, she will not seek re-election at tomorrow's Annual General Meeting (the "AGM").

 

As the Company's AGM Notice has already been issued, the Company confirms that the resolution to reappoint Anne Fahy as a Non-Executive Director of the Company (Resolution 8) is now withdrawn. The withdrawal of Resolution 8 does not otherwise affect the validity of the Notice of Meeting, or any proxy votes already submitted on other proposed resolutions. The numbering of all other proposed resolutions at the AGM will remain unchanged.

 

The Board and its Committees will now commence a process to select Anne's successor in her role as Non-Executive Director and Chair of the Audit Committee and an announcement will be made in this regard in due course. In the interim period, Barrie Brien will be appointed as Interim Chair of the Audit Committee in respect of any scheduled Committee meetings which may take place before a new Chair is appointed. Barrie brings extensive financial experience, having held the role of Chief Operating and Financial Officer at Creston PLC between 2004 and 2014.

 

James Bilefield, Non-Executive Chair, commented:

 

"On behalf of the Board, I would like to thank Anne for her valued contribution to the Company over many years. She has provided the Group with a wealth of experience during a period which has seen significant growth and expansion. We wish her well for the future."

 

 

- Ends -

 

 

Enquiries:

 

 

SThree plc

 

James Bilefield, Chair

Andrew Beach, CFO

Kate Danson, General Counsel and Group Company Secretary

 

 

 via Alma

Alma PR

+44 20 3405 0205

 

Rebecca Sanders-Hewett

Susie Hudson

SThree@almapr.co.uk

 

 

Notes to editors

SThree plc brings skilled people together to build the future. We are the only global pure-play specialist staffing business focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), providing permanent and flexible contract talent to a diverse base of over 8,000 clients across 14 countries. Our Group's c.2,700 staff cover the Technology, Life Sciences, Engineering and Banking & Finance sectors. SThree is part of the Industrial Services sector. We are listed on the Premium Segment of the London Stock Exchange's Main Market, trading with ticker code STEM.

 


ISIN:GB00B0KM9T71
Category Code:MSCL
TIDM:STEM
LEI Code:2138003NEBX5VRP3EX50
Sequence No.:156114
EQS News ID:1329619
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSFY25 Q1 Trading Update
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20253:45 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20253:00 pmRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20254:45 pmRNSDirector/PDMR Shareholding
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 202512:30 pmRNSAnnual Financial Report
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20259:55 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 202510:51 amRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20254:01 pmRNSBlock listing Interim Review
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 202510:35 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20254:36 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.